The aim of quality improvement is to provide assurance to the public and professionals that the sickle cell and thalassaemia screening programme is a high quality programme. The SCT programme uses the term quality improvement rather than quality assurance as quality improvement more clearly describes our aims.
Quality improvement and performance management are an integral part of any national screening programme, to ensure that the programme achieves the highest possible standards. It is important for:
- Service users
- To reduce costs and provide a better service.
Service quality is dynamic and standards need to be continually reviewed and tightened so that quality is maintained and progressively increased.
The linked NHS Sickle Cell and Thalassaemia Screening Programme is delivered across professional and organisational boundaries. Therefore, in order to achieve accessibility, equity and access to services within an acceptable cost, clear pathways and robust partnerships are required. Communication is a key aspect of maintaining quality in this environment, and a coordinated plan is required to ensure that individual processes do not appear disjointed. User involvement in the process is also recommended.